Colon Cancer p53 Hotspot Mutation Cell Panel (ATCC^® TCP-2020^™)

LS174T, ATCC CL-188

SW48, ATCC CCL-231

LS123, ATCC CCL-255

LS1034, ATCC CRL-2158

COLO 320DM, ATCC CCL-220

WiDr, ATCC CCL-218

Biological understanding of top genetic alterations across tumor types

Novel anti-cancer drug targeting

Reactivation of mutant p53

Studies related to p53 molecular mechanisms

Testing small molecules or biologics for cancer drug development

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

The Colon Cancer p53 Hotspot Mutation Cell Panel is comprised of 6 select cell lines derived from colon cancer that have been sequenced and validated by ATCC. The panel includes both WT p53 cell lines as well as cultures with p53 hotspot mutations at codons 175, 245, 248, or 273.